The GARS1 gene helps cells build proteins by linking glycine, a protein building block, to transfer RNA, the molecule that guides protein assembly. This gene plays an important role in helping long nerve cells stay healthy. If the gene is not working properly, people may develop Charcot-Marie disease or related inherited nerve conditions, with weakness and muscle loss often starting in the hands or feet. Some GARS1 variants cause earlier and more widespread symptoms, including breathing or feeding problems in infancy.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or regulate processes in the body. Some genes carry the directions for making proteins, the active parts of cells. Others mainly determine when, where, and how much certain processes take place. As a whole, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To go into this topic in more detail, you can find more in the LearnHub.
Overview
GARS1Gene function
What if the gene works
The GARS1 gene helps cells make proteins by linking glycine to a helper molecule called transfer RNA. This supports routine cell function throughout the body, including in nerve cells.
Risk
What if the gene does not work
Variants in the GARS1 gene can affect nerve cells, often causing hand weakness, muscle wasting, and foot problems. Milder variants may lead to progressive peripheral neuropathy, while more severe variants can cause early widespread weakness, delayed development, and breathing difficulties.
Treatment
What does that mean for your treatment
No treatment or drug choice tied specifically to the GARS1 gene is currently established in clinical guidelines for people with pathogenic variants in the GARS1 gene. Research is exploring experimental approaches, including gene based strategies and compounds that may lessen the effects of some GARS1 variants, but this work remains early stage.
Conditions associated with GARS1
Gene function
What if the gene works
Every day, your cells need new proteins to grow, repair, and stay organized. The GARS1 gene helps prepare glycine, one of the body’s protein building blocks, so cells can place it correctly during protein production. This is a key part of how the GARS1 gene helps make proteins in both the main part of the cell and in mitochondria, the cell’s energy-making parts.
The GARS1 gene attaches glycine to its matching transfer RNA, a small helper used during protein building. This gives the cell a glycine-ready tool before the protein assembly process begins.
By preparing glycine in the right form, this gene helps cells read genetic instructions more accurately during protein production. That supports steady day to day cell function across many tissues.
The GARS1 gene also works in mitochondria, the parts of cells that make energy. There, it helps produce the small set of proteins mitochondria need for routine energy work.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants have no noticeable effect and simply reflect natural genetic variation. Sometimes, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many GARS1 gene variants change the shape of the protein enough to reduce how well cells attach glycine to transfer RNA, a key step in protein building. Some also make the protein less stable or create abnormal interactions in long nerve cells. These changes show how GARS1 gene variants affect protein function: milder variants may leave partial activity, while more disruptive variants can alter the protein more strongly and are often linked to earlier or more severe nerve problems.
How variants are linked to conditions
Pathogenic variants in the GARS1 gene cause inherited nerve conditions, most often Charcot-Marie-Tooth disease type 2D and distal hereditary motor neuropathy type V. In many people, GARS1 gene variants linked to Charcot-Marie-Tooth disease lead to weakness and wasting that starts in the hands and can later affect the feet and lower legs. Less often, variants in the GARS1 gene are associated with earlier-onset and more widespread neuropathy.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal part of being human. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For GARS1-related conditions, risk is mainly shaped by the specific gene change and whether it runs in the family. There is not yet broadly confirmed evidence that lifestyle or environmental factors clearly increase or lower this genetic risk. Anyone concerned about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of GARS1 variants
Most disease-causing changes in the GARS1 gene are inherited in an autosomal dominant pattern, which is the main answer to how GARS1 gene variants are inherited. This means a parent with the variant has a 50% chance of passing it to each child. Sons and daughters can inherit it equally because the GARS1 gene is on chromosome 7, not a sex chromosome. Some people with a GARS1-related condition have a new, de novo variant that was not inherited from either parent.
What does my GARS1 result mean for my family?
For many GARS1-related nerve conditions, the pattern is dominant, which means close relatives such as a parent, brother, sister, or child may also carry the same gene change and may want to learn whether it runs in the family. In some families, the change starts new in one person, so it is not always inherited from a parent. The exact family impact can vary with the specific GARS1 result and the condition linked to it.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the GARS1 gene, clinicians use genetic testing for GARS1 variants on a blood sample or cheek swab. A lab reads the gene’s DNA code and compares it with the usual sequence, which can confirm a disease-causing variant, identify a benign change, or sometimes find a result that needs expert interpretation.
When should I consider getting a genetic test?
Consider genetic testing for the GARS1 gene if you or close relatives have an inherited pattern of muscle weakness or wasting in the hands and feet, often starting in childhood or early adulthood. A test can help confirm whether a GARS1-related nerve condition is the cause and clarify family risk.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and the specific type of variant. Over time, many other factors also shape how the body works, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how a person responds to medicines. Some people break down a drug faster or slower than others, so the same treatment may work better, work less well, or cause more side effects. These differences are common and are one reason medication response can vary from one person to the next.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape the way a person responds to medication. It studies the relationship between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes can influence how the body handles a drug or how strong its effects are. This information can support treatment decisions that are more informed and more individualized. More details on this topic are available in the LearnHub.
Drugs influenced by the GARS1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or which side effects are more likely. If you have questions about symptoms, treatment choices, or possible medication side effects, talk with your doctor or pharmacist.
History
GARS1 entered medical genetics in the early 2000s, when researchers linked variants in this gene to inherited nerve conditions now known as Charcot-Marie-Tooth disease type 2D and distal hereditary motor neuropathy. This was an important shift because it showed that a gene involved in a basic cell process could still cause a very specific nerve condition. Initially understood only through visible traits, later recognized as tied to a specific gene, these family patterns helped connect longstanding clinical observations with DNA findings. From these first observations, research expanded steadily. Over time, scientists found that different GARS1 variants could be linked to somewhat different patterns of weakness and age at onset. This work helped broaden how doctors and researchers think about inherited neuropathies.